Application
Fig1: Western blot analysis of CBX2 on human CBX2 recombinant protein using anti-CBX2 antibody at 1/1,000 dilution.
Application
Fig2: Western blot analysis of CBX2 on HEK293 (1) and CBX2-hIgGFc transfected HEK293 (2) cell lysate using anti-CBX2 antibody at 1/1,000 dilution.
Application
Fig3: Western blot analysis of CBX2 on different cell lysate using anti-CBX2 antibody at 1/1,000 dilution. Positive control: Line1: HUVEC Line2: HEK293 Line3: Hela Line4: NIH/3T3 Line5: A431
Application
Fig4: ICC staining CBX2 (green) and Actin filaments (red) in MCF-7 cells. The nuclear counter stain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilised with 0.25% Triton X100/PBS.
Application
Fig5: Immunohistochemical analysis of paraffin-embedded human cervical cancer tissues using anti-CBX2 antibody. Counter stained with hematoxylin.
Application
Fig6: Immunohistochemical analysis of paraffin-embedded human rectum cancer tissues using anti-CBX2 antibody. Counter stained with hematoxylin.
Application
Fig7: Flow cytometric analysis of Hela cells with CBX2 antibody at 1/100 dilution (green) compared with an unlabelled control (cells without incubation with primary antibody; red).